Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers

Satoshi Tsunetoh(Osaka Medical and Pharmaceutical University), Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Hiroshi Kawaguchi(New Tokyo Hospital), Yoshiki Yamashita(Osaka Medical and Pharmaceutical University), Yoshito Terai(Osaka Medical and Pharmaceutical University), Tatsuharu Sekijima(Osaka Medical and Pharmaceutical University), Hiroshi Sasaki(Jikei University School of Medicine), Masanori Kanemura(Osaka Medical and Pharmaceutical University), Akiko Tanabe(Osaka Medical and Pharmaceutical University), Satoe Fujioka(Osaka Medical and Pharmaceutical University), Yoshimichi Tanaka(Osaka Medical and Pharmaceutical University)
Cancer Biology & Therapy
December 1, 2010
10.4161/cbt.10.11.13443
Cited by 26

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
Autophagy modulates osteoarthritis‐related gene expression in human chondrocytes
|Arthritis & Rheumatism|2011|265
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212
Estrogen Suppresses Transcription of Lipoprotein Lipase Gene
|Journal of Biological Chemistry|2000|209